Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 16 Colorectal Neoplasms 7 Small Cell Lung Carcinoma 4 Neoplasm Metastasis 4 Stomach Neoplasms 3 Recurrence 3 Biliary Tract Neoplasms 3 Sarcoma, Ewing 2 Rhabdomyosarcoma 2 Ovarian Neoplasms 2 Nasopharyngeal Carcinoma 2 Fallopian Tube Neoplasms 2 Cholangiocarcinoma 2 Triple Negative Breast Neoplasms 1 Somatostatinoma 1 Solid Tumor 1 Small Cell Lung Cancer Extensive Stage 1 Small Bowel Adenocarcinoma 1 Rectal Neoplasms 1 Rectal Cancer Patients 1 Pancreatic Ductal Adenocarcinoma 1 Pancreatic Cancer Non-resectable 1 Pancreatic Cancer Metastatic to Liver 1 Pancreatic Adenocarcinoma 1 PDAC - Pancreatic Ductal Adenocarcinoma 1 Osteosarcoma 1 Neoplasms 1 Neoadjuvant Chemotherapy 1 Metastatic Pancreatic Adenocarcinoma 1 Locally Advanced Rectal Cancer (LARC) 1

Interventions

Cisplatin 88 Fluorouracil 71 Paclitaxel 69 Radiotherapy 63 Oxaliplatin 55 Irinotecan 37 Docetaxel 36 Carboplatin 36 Leucovorin 34 Capecitabine 28 Radiation 25 Surgical Procedures, Operative 22 Drug Therapy 19 pembrolizumab 18 Cetuximab 15 Bevacizumab 15 Nivolumab 14 tislelizumab 12 camrelizumab 11 Neoadjuvant Therapy 11 Esophagectomy 11 Chemoradiotherapy 11 S 1 (combination) 10 Albumin-Bound Paclitaxel 10 nimotuzumab 9 Trastuzumab 9 durvalumab 8 Radiotherapy, Intensity-Modulated 8 Gefitinib 7 Epirubicin 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Esophageal Neoplasms × irinotecan sucrosofate × Clear all

NCT03764553 2026-04-07

LyRICX

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase 2 Active not recruiting

Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡